Dividend per share of the pharmaceutical company Recordati 2013-2023

Published by
Juliette Gagliardi,
Jun 13, 2024

The dividend per share of Italian pharmaceutical company Recordati increased steadily from 2013 to 2022. As a matter of fact, dividends of the group peaked at 1.2 euros per share in 2023. This statistic depicts the dividend per share (EPS) of the Italian pharmaceutical company Recordati from 2013 to 2023 (in euros).

Dividend per share (EPS) of the Italian pharmaceutical company Recordati from 2013 to 2023 (in euros)

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

April 2024

Region

Europe, Italy

Survey time period

2013 to 2023

Supplementary notes

Recordati is an international group headquartered in Milan, whose branches are operational all over the world.

Figures prior to 2018 were retrieved from different reports published by the source.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in Norway "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Norway

Overview

5

Pharmaceutical revenue

5

Production and trade

4

R&D, patents and new products

4

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Orphan drugsGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsDiseases
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.